GlassScriptPhysician profile
Ruth A Mcwilliams
NPI 1972077675
$4,648.08
in general payments reported to CMS, 2019-2025
21 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.39 · 2022: $1,828 · 2023: $1,125 · 2024: $342 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,779.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,583.52 | 2022-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Aop Health US, LLC | $712.88 | 2025 | Rapiblyk |
| Boston Scientific Corporation | $652.27 | 2021-2025 | Watchman Access System, Watchman Flx |
| Abbott Laboratories | $340.04 | 2023-2025 | Aveir, Amplatzer Amulet, Confirm Rx |
| Atricure, INC. | $265.44 | 2022-2023 | |
| Pfizer INC. | $162.65 | 2022-2025 | |
| Novo Nordisk INC | $146.50 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Impulse Dynamics (USA) INC. | $141.01 | 2022 | |
| Amgen INC. | $95.07 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.18 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $78.65 | 2022-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $60.49 | 2023-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $57.49 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $54.18 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $50.91 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $45.44 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals, LTD. | $40.23 | 2023 | Arcalyst |
| Genzyme Corporation | $22.51 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.48 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $17.16 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.98 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Mcwilliams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.